A world-class industrial partner for custom synthesis and formulation of niche products in Healthcare.
M2I Vision :Build in France a world-class industrial partner for custom synthesis and formulation of niche products in Healthcare (mainly generics), veterinary art, biological crop protection and organic electronics(Re)design synthetic routes and industrial processes for « hard to make » molecules (core capability)Propose to our clients a one stop shop from specification to regulatory clearance (DMF, MA) by teaming up with R&D and marketing teamsThe company operates a R&D center rance and a cGMP manufacturing plant.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 14, 2020 | Debt Financing | — | 1 | — | — | Detail |
Sep 3, 2019 | Series Unknown | €60M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Bootstrap Europe | — | Debt Financing |
France 2i | — | Series Unknown |